Manufacturer
RANBAXY LABORATORIES LIMITED
Contents
Irbesartan
Indication
Hypertension and Diabetic nephropathy in Type 2 diabetes mellitus.
Instruction
May be taken with or without food.
Drug interaction
May antagonise hypotensive effect and increase risk of nephrotoxicity w/ NSAIDs. May increase serum lithium levels and toxicity. Increased risk of hyperkalaemia w/ K-sparing diuretics (e.g. amiloride, triamterene, spironolactone), K supplements or K-containing salt substitutes.Potentially Fatal: May increase nephrotoxic, hyperkalaemic and hypotensive effect w/ aliskiren in patients w/ diabetes and renal impairment (GFR <60 mL/min).
Malaysia
